Periodical flux monitoring demonstrated that xenograft tumors with LV-PDIA4 exhibited higher total flux compared to the LV-Ctrl, indicating that PDIA4 drives greater progressive tumor growth in vivo (Fig. 5D). Here, PDIA4 is linked to neoplasm.